Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
grade D 0.54 -12.90% -0.08
EARS closed down 12.9 percent on Friday, November 16, 2018, on 30 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical EARS trend table...

Date Alert Name Type % Chg
Nov 16 Fell Below 50 DMA Bearish 0.00%
Nov 16 New Downtrend Bearish 0.00%
Nov 16 Wide Bands Range Expansion 0.00%
Nov 16 Down 3 Days in a Row Weakness 0.00%
Nov 16 Down 4 Days in a Row Weakness 0.00%
Nov 16 Down 5 Days in a Row Weakness 0.00%
Nov 16 Lower Bollinger Band Touch Weakness 0.00%
Nov 16 Oversold Stochastic Weakness 0.00%
Nov 15 50 DMA Support Bullish -12.90%
Nov 15 1,2,3 Pullback Bullish Bullish Swing Setup -12.90%

Older signals for EARS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.
Is EARS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.5
52 Week Low 0.23
Average Volume 8,440,005
200-Day Moving Average 1.1184
50-Day Moving Average 0.6144
20-Day Moving Average 0.7342
10-Day Moving Average 0.6806
Average True Range 0.148
ADX 32.13
+DI 23.3874
-DI 25.4394
Chandelier Exit (Long, 3 ATRs ) 0.796
Chandelier Exit (Short, 3 ATRs ) 0.874
Upper Bollinger Band 0.9686
Lower Bollinger Band 0.4998
Percent B (%b) 0.09
BandWidth 63.851812
MACD Line -0.0205
MACD Signal Line 0.0146
MACD Histogram -0.0351
Fundamentals Value
Market Cap 23.94 Million
Num Shares 44.3 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -0.72
Price-to-Sales 0.00
Price-to-Book 6.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.86
Resistance 3 (R3) 0.85 0.75 0.80
Resistance 2 (R2) 0.75 0.67 0.75 0.78
Resistance 1 (R1) 0.64 0.62 0.59 0.65 0.77
Pivot Point 0.54 0.54 0.51 0.54 0.54
Support 1 (S1) 0.43 0.46 0.38 0.44 0.31
Support 2 (S2) 0.33 0.41 0.33 0.30
Support 3 (S3) 0.22 0.33 0.28
Support 4 (S4) 0.23